Cannabis in the Finger Lakes: Read all about it –

Someday in the near future, a shopper may enter a cannabis dispensary somewhere in New York, perhaps Canandaigua. 

Depending on the size of the store, you may find 50 to 75 brands of edible cannabis. Along another wall, 50 to 75 tinctures, or drops. And still, there’s even more cannabis products to choose from, according to Nate Kurash, a Rushville resident of five years and founder of „FLX420,” a soon-to-be-released magazine dedicated to the cannabis culture. 

“When you walk into these dispensaries, it’s like walking into a cigar store or wine store. There are literally hundreds of options for people to choose from,” Kurash said. “Getting people educated on what to choose, what’s right for them, brand recognition — it could be very overwhelming if you don’t know what you’re doing.” 

Kurash is aiming to help with the magazine, which is set to launch in April. He’s also setting the groundwork for his involvement in the nascent New York cannabis industry. He plans to pursue cannabis licensing here, as he did in Missouri when he first entered the business. 

Curiosity got Kurash, a native of Cleveland, Ohio, and a sales professional in the medical industry by trade, into cannabis.  

“Over my adult life I started seeing a lot of friends and acquaintances move away from alcohol towards cannabis,” Kurash said. “I was also hearing stories of people getting medical benefits from cannabis ranging from pain relief (to) help with insomnia and anxiety. All of which I had experienced myself.” 

Kurash joined a group that pursued medical cannabis licenses in Missouri and was successful in winning three cultivation and three processing licenses. 

He’s expecting similar success in New York, in particular the Finger Lakes region he now calls home. 

“The amazing success of the wineries and the existing tourism infrastructure that exists will definitely help pave the way for the adult-use cannabis industry,” Kurash said. “For this region to be successful I also believe that the those living here must fully embrace what is coming and want to make it succeed. The majority of people that I have spoken with have a very positive attitude and an openness to what lies ahead. This, combined with the abundance of agriculture land for growing cannabis, puts this region on a path towards prosperity.” 

Any such efforts in New York will take time. 

It’s only been about a year now for a person to legally have and use up to 3 ounces of marijuana, but businesses will have to seek licenses in order to operate a cannabis business. 

Canandaigua City Manager John Goodwin said he is not aware of interest in operating dispensaries in the city at this point, but that could be because the state has yet to implement its regulatory structure. City Council last year gave the OK for a retail dispensary to operate in the city, but a retail location for consumption — and consumption on public property, for that matter — are not allowed.

“It’s been our understanding that there won’t be anything that would be opened and operational until sometime in the spring of 2023,” Goodwin said. “It’s going to be awhile before we see retail dispensaries open up.” 

In the meantime, FLX420, Kurash said, will help to lay the groundwork for the cannabis industry. A lot of education needs to be done, he said, and a magazine is a vehicle to accomplish that. 

„I want to make sure the infrastructure is in place for a successful industry, but if you don’t have the consumers, no matter how many dispensaries you have, it’s not going to go anywhere,” Kurash said.

The first issue is scheduled to come out April 20 — 4/20 — which will coincide with a number of networking events. He plans to publish four print and online issues this year with the ultimate goal of coming out monthly.

Among the reasons he is launching the magazine is to help connect the cannabis consumer to those who will be growing and selling cannabis as well as those businesses that will support those consumers who choose to grow their own.

“Ultimately, I want the magazine to be a trusted one-stop shop for everything related to the adult-use cannabis industry here in the Finger Lakes region and surrounding areas,” Kurash said. 

How CBD impacts the brain – Maddyness

Changes to laws surrounding the cannabis plant since the turn of the century, have meant scientists can once again study the plant in greater detail. With more in depth studies, come more in depth uses for the compounds found in the plant.

What is CBD?

One of over 60 cannabinoids found in the cannabis plant, CBD is a non-psychoactive chemical compound which can be extracted from industrial hemp. A 2018 World health Organisation (WHO) report found there to have been no incidences of abuse, dependence or negative impacts on health from the use of CBD.

How does it work?

Once consumed, the compound interacts with the body’s endocannabinoid system (ECS). The ECS is a biological system within the human body that is made up of neurotransmitters which attach with cannabinoid receptors and their receptor proteins.

Making up part of the central nervous system, the ECS acts like a bridge between the brain and body. It is responsible for management of pain, sleeping patterns, appetite and immune response, amongst other bodily functions.

How does CBD affect your mood?

The receptors in the ECS react to hormones, as hormones play such a large part in your demeanour, their levels can determine your mood. CBD promotes the production of hormones and can help you find the balance you need to elevate your mood and remain productive.

Two such hormones are serotonin and dopamine. Responsible for keeping you content and calm, but also engaged and excited, a healthy balance of serotonin and dopamine is crucial to productive functionality.

Promoting good moods

Dopamine is the hormone that is released when you partake in a high energy or exhilarating activity. When you finish a run, jump out of a plane, or even just watch sport, the excitement you experience is a dopamine release. Dopamine is like a reward system any pleasurable activity and the reason for thrill seeking.

Serotonin works in much the same way, except it is a little more to do with activity. When you partake in physical activity the bodies muscles produce tryptophan. This amino acid is what your brain uses to produce serotonin and leads to the ‘high’ sensation felt after a run or visit to the gym.

These two hormones help with appetite, memory, libido and sleeping patterns, as well as many other important functions within the body. Sun light, exercise, sleep and even massages can all help with the production of serotonin and dopamine. Having the right balance of these activities means levels of the hormones do not end up depleted.

With serotonin and dopamine reliant heavily on sleep for their production, a healthy sleeping pattern is essential. As a relaxant, CBD helps calm the mind and body making it easier to wind down. With reduced anxiety and stress, the ‘promise-land of nod’ should be much easier to reach.

Working away whilst you sleep, CBD has also been shown to reduce sleep disturbances such as nightmares. By helping you maintain sleep cycles, your brain has a chance to regenerate all the essential hormones needed for a successful and productive day.

Diminishing dark thoughts

As well as producing hormones, CBD can also help in reducing them. Studies have shown that CBD can alter the flow of blood in the brain. In reducing the flow of blood to the area of the brain responsible for anxiety, a person’s sense of anxiety is also reduced.

An anxious brain produces a hormone called cortisol. This can have a negative impact on the brain’s response to situations and to general well-being. Reducing the flow of blood to the area responsible for anxiety reduces the production of cortisol and in turn, helps you to relax.

When the brain is stressed, it experiences systemic inflammation, this also sees more cortisol released into the body. As CBD has natural anti-inflammatory properties, it helps to reduce the swelling, reducing stress and levels of cortisol.

CBD as an anti-Inflammatory

The anti-inflammatory properties of CBD can be attributed to much of its success as a medicine. As we mentioned earlier, the flow of blood and reduction in swelling on the brain has an overall positive affect on the mind and body.

There are many cognitive impairments associated with swelling on the brain that CBD can help with. Associated with anxiety, ADHD, depression, Alzheimer’s, bi-polar or just stress, this swelling can be reduced with routine CBD intake.

Another benefit of CBD is its work as an antioxidant. Over time, oxygen can damage areas of our brain and CBD works to counter the oxidative corrosion in the brain, improving its shelf-life.

One common issue with strong links to oxidative damage is Parkinson’s Disease. Using CBD as part of a daily routine will alleviate the death of brain cells through oxidative corrosion, of which we are all susceptible to by simply living.

CBD and the wellbeing market

As we uncover more and more about the plant, governments and governing bodies have been much less restrictive on access to CBD. Companies like Goodrays in the UK are manufacturing and distributing various products that contain a healthy dose of the compound, delivered in a consumable such as soft drink or sweet.

Using certified CBD isolate (0% THC), their offerings are a simple solution making CBD part of your daily life. As simple as opening a can and drinking, 20mg of CBD are delivered into the body and get to work connecting with your endocannabinoid system.

The wellness market craves organic products, and as such the products Goodrays promote are healthy, organic, recyclable and sustainably sourced. Their work aims to bring to light the benefits found in the cannabis plants as well as bringing about a better way of life for their customers.

In a world where everybody is trying to be a little more productive, whilst leaving less of a footprint on the planet, Goodrays seem to have found a solution. You can visit their website here.

Lake Placid inches closer to March election on cannabis | News, Sports, Jobs – The Adirondack Daily Enterprise

LAKE PLACID — The village board of trustees last week passed two resolutions to place the village’s cannabis laws on a special election ballot. The election will take place on March 15, and these cannabis laws will be the only thing on the ballot.

Recreational marijuana was legalized statewide last March, and local governments had until Dec. 31, 2021 to pass local laws opting out of allowing dispensaries and/or on-site consumption licensing within their boundaries. Thirty-four percent of the state’s municipalities opted out of all cannabis sales last year, according to data from the state Office of Cannabis Management. The village board unanimously voted last December to opt out with the intention of placing its cannabis laws on the ballot to give voting village residents the final say.

“The voters will tell us what they want,” village Mayor Art Devlin said last week.

Village governments, unlike town governments, had the ability to opt out and then pass a resolution to place their cannabis laws on a ballot, which is the process the village board decided to begin last year.

Village Clerk Anita Estling said Tuesday that people with pandemic-related concerns, along with people who will be out of town for the election and people who have a disability, will be able to request absentee ballots for the election. Anyone who wants to apply for an absentee ballot should email their request to Estling at

The North Elba Town Hall reopened its doors this week, and Estling said that barring any future COVID-19 spikes in Lake Placid, town hall should be open for voting from noon to 9 p.m. on Election Day, March 15.

Village attorney Janet Bliss recommended last week that the village make a sample ballot available to residents who plan on voting in the special election. Estling said she expects the sample ballot to be available by early February. The village plans to release the sample ballot on the village Facebook page and website.

Since the two adopted local laws are opting out of cannabis dispensaries and on-site consumption licensing, anyone who wants to vote in favor of opting back in to either option would vote against the adopted laws. A “no” vote to either law would translate to a “yes” to opting in. A “yes” vote to either law would be a vote to stay opted out. If the local laws are upheld, the village board could still vote to opt in to either option in the future.

The ballot was originally expected to include both the cannabis laws and one seat on the board of trustees, since trustee Jason Leon was elected to the North Elba Town Council this past November. Now, Leon plans to serve on the North Elba council while remaining on the village board, so his seat won’t be on the ballot. He said that to avoid conflicts of interest, he’ll bow out from the village board when it begins budget discussions.

Today’s breaking news and more in your inbox

Ambient Vaporizer Market Report SWOT Analysis by 2031 | Linde Engineering, Sing Swee Bee Enterprise, Cryolor, Cryoquip – The Oxford Spokesman – The Oxford Spokesman

New Jersey, United States,- Market Research Intellect has released a new publication on the Ambient Vaporizer market, which has the title “Analysis and forecast of the Ambient Vaporizer market 2022.”The publication provides an in-depth assessment of the global automotive chassis dynamometers market based on competition, market dynamics, market segmentation and other vital aspects.

The market research report is a compilation of comprehensive intelligence studies that explore almost every aspect of the global Ambient Vaporizer market. Market participants can use the report to learn more about the competitive landscape and the level of competition in Ambient Vaporizer market. The report presents itself as a powerful tool that players can use to prepare to secure the lion’s share of the global Ambient Vaporizer market. In addition, it evaluates each segment of the Ambient Vaporizer market in detail so that readers can be informed about future opportunities and high-growth areas of the industry. In addition, it offers a comprehensive study of the crucial market dynamics, including growth drivers, constraints, challenges, trends and opportunities.

Get | Download Sample Copy with TOC, Graphs & List of Figures@

The authors of the report provide an encyclopedic account of the main regional markets and their progress in recent years. Readers receive accurate facts and figures related to Ambient Vaporizer market and its important factors such as consumption, production, revenue growth and CAGR. The report also shares the gross margin, market share, attractiveness index and value and volume growth of all segments studied by analysts. It highlights key developments, the product portfolio, the markets served and other areas that describe the growth of the activities of the main companies described in the report.

The report was prepared using the latest primary and secondary research methodologies and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports and public and private interviews to collect data and information related to the market in which they work.

The major players covered in Ambient Vaporizer Markets:

  • Linde Engineering
  • Sing Swee Bee Enterprise
  • Cryolor
  • Cryoquip
  • Cryonorm
  • Triumph
  • Fiba Technologies
  • Fuping Gas Equipment
  • Isisan Isi
  • Chart Industries
  • Inox India

Ambient Vaporizer Market Breakdown by Type:

  • Linde Engineering
  • Sing Swee Bee Enterprise
  • Cryolor
  • Cryoquip
  • Cryonorm
  • Triumph
  • Fiba Technologies
  • Fuping Gas Equipment
  • Isisan Isi
  • Chart Industries
  • Inox India

Ambient Vaporizer Market breakdown by application:

  • Linde Engineering
  • Sing Swee Bee Enterprise
  • Cryolor
  • Cryoquip
  • Cryonorm
  • Triumph
  • Fiba Technologies
  • Fuping Gas Equipment
  • Isisan Isi
  • Chart Industries
  • Inox India Engineering
  • Sing Swee Bee Enterprise
  • Cryolor
  • Cryoquip
  • Cryonorm
  • Triumph
  • Fiba Technologies
  • Fuping Gas Equipment
  • Isisan Isi
  • Chart Industries
  • Inox India

The Ambient Vaporizer market report has been separated according to separate categories, such as product type, application, end-user, and region. Each segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Ambient Vaporizers market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders and market participants in order to get a complete picture of the global Ambient Vaporizers market and its growth potential in the coming years.

Get | Discount On The Purchase Of This Report @

Ambient Vaporizer Market Report Scope

Report Attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast Period 2021 – 2028
Quantitative units Revenue in USD million and CAGR from 2021 to 2027
Segments Covered Types, Applications, End-Users, and more.
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization scope Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Regional market analysis Ambient Vaporizer can be represented as follows:

Each regional Ambient Vaporizer sectors is carefully studied to understand its current and future growth scenarios. This helps players to strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

The base of geography, the world market of Ambient Vaporizer has segmented as follows:

    • North America includes the United States, Canada, and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria, and Chile
    • The Asia Pacific includes Japan, China, Korea, India, Saudi Arabia, and Southeast Asia


Key questions answered in the report:

  • What is the growth potential of the Ambient Vaporizer markets?
  • Which product segment will get the lion’s share?
  • Which regional market will emerge as a forerunner in the coming years?
  • Which application segment will grow at a steady pace?
  • What are the growth opportunities that could emerge in the lock washer industry in the coming years?
  • What are the main challenges that the global Ambient Vaporizer markets could face in the future?
  • What are the leading companies in the world market of Ambient Vaporizer?
  • What are the main trends that have a positive impact on the growth of the market?
  • What are the growth strategies envisaged by the players to maintain their grip on the global market for Ambient Vaporizer?


For More Information or Query or Customization Before Buying, Visit @

The study explores in depth the profiles of the main market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants as they design their business strategies. This report covers production, revenue, market share and growth rate of the Ambient Vaporizer market for each key company, and covers breakdown data (production, consumption, revenue and market share) by regions, type and applications. Ambient Vaporizer historical breakdown data from 2016 to 2020 and forecast to 2021-2029.

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations in addition to the objective of delivering customized and in-depth research studies.We speak to looking logical research solutions, custom consulting, and in-severity data analysis lid a range of industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverages. Etc Our research studies assist our clients to make higher data-driven decisions, admit push forecasts, capitalize coarsely with opportunities and optimize efficiency by bustling as their belt in crime to adopt accurate and indispensable mention without compromise.Having serviced on the pinnacle of 5000+ clients, we have provided expertly-behaved assert research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony, and Hitachi.

Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll-Free: +1 (800)-782-1768

Website: –

Bill to limit THC in pot sold at dispensaries draws swift backlash: ‘It’s almost impossible’ – Chicago Sun-Times

A bill introduced in Springfield last week that would limit the key mind-altering ingredient found in legal pot products has drawn swift pushback from both cannabis advocates and an influential trade group.

State Rep. Mark Batinick, R-Plainfield, said he introduced the bill ahead of a filing deadline at the behest of the Illinois State Medical Society, whose members have concerns about potency and the “skyrocketing” number of cannabis-related calls received by the Illinois Poison Center.

Those calls jumped from 487 in 2019 to 743 in 2020 — when cannabis was fully legalized — and then climbed to 855 last year. Many were related to the consumption of pot-infused edibles, the poison center reported.

Batinick’s proposal would cap the amount of THC in cannabis flower at 10% and set a 15% limit for concentrates and infused products. Pam Althoff, executive director of the Cannabis Business Association, believes that such regulation would be unprecedented — and a burden on weed producers.

“It’s almost impossible, practically, to be able to do this,” added Althoff, who believes lawmakers should instead be focused on regulating alternative hemp-derived cannabinoids, like Delta-8 and THC-O, that don’t face the same stringent testing and oversight as legal weed products.

Many shoppers currently make purchases based on THC content, and legal pot products found on dispensary shelves are typically far more potent than the proposed levels. Many marijuana flower strains have 20-30% THC. But at least one concentrated cannabis product currently available at a Chicago dispensary has a listed THC value of more than 80%.

While Batinick said the bill was merely filed “more from a discussion standpoint” and “isn’t necessarily going to move,” he noted it’s already led to some “nasty emails” from critics.

That’s not terribly surprising since the National Organization for the Reform of Marijuana Laws, the nation’s oldest cannabis lobbying entity, blasted out an email Tuesday urging supporters to contact lawmakers to express opposition to the bill.

“If passed, this bill would significantly limit access to stronger forms of cannabis, with the most detrimental impacts falling on those who rely on marijuana for its medicinal properties,” the email said. “Just as conventional medicines are readily available in a variety of strengths and potencies in order to meet individual patients’ needs, medicinal cannabis and regulated products in general should be available in varying potencies and formulations.”

The email noted that weed can’t cause lethal overdoses. NORML further warned that THC caps would limit access to medical cannabis and drive more consumers into the already thriving black market, a concern shared by Althoff.

Batinick insisted the bill “isn’t meant to affect medical marijuana at all” and said he’s merely looking to “find balance and keep people safe.” What’s more, he acknowledged the proposal is subject to change: “Nobody’s usually perfect on their first swing.”

The medical society acknowledged it will be difficult to get the legislation passed: “At the direction of our membership, ISMS requested this legislation be introduced,” spokeswoman Jann Ingmire said. “However, we know it faces an uphill battle.”

State Rep. La Shawn Ford, a Chicago Democrat who sponsored recent legislation that overhauled the legalization law, said he’s open to having a conversation — even though he thinks the current version of Batinick’s bill is a “nonstarter.”

“I think that it advances the conversation as we go forward,” Ford said. “These are the type of discussions that we need to have. It’s definitely a concern of some people, so we should be dealing with it. But that doesn’t mean it passes.”

Sonoma County supervisors approve tax delay for cannabis cultivators – North Bay Business Journal

Sonoma County cannabis growers will have another three months to pony up their cultivation taxes under a reprieve granted Tuesday by the Board of Supervisors.

The board voted unanimously, without discussion, to delay the due date for first quarter taxes from Jan. 31 to April 30. Total taxes due for both quarters would be due without penalties or interest, on April 30 unless the board approves another extension.

The temporary measure comes as local growers and industry advocates have been engaged in a monthslong push for tax relief, with a recent tax hike at the state level adding to the urgency of their campaign.

The state taxes growers by the ounce. State and local jurisdictions also charge excise tax at point-of-sale of up to 15%.

In addition, Sonoma County taxes local growers at different rates on a per-square-foot basis for outdoor, indoor and mixed light crops. Cities can also add their own taxes.

During the board’s Jan. 4 meeting on the issue, multiple Sonoma County marijuana farmers and industry advocates said growers were unable to keep up with the high costs and so were either selling out to corporate operators or dropping into the black market.

About 170 licensed cannabis cultivators, five dispensaries and five manufacturers pay taxes to the county, according to Auditor-Controller-Treasurer-Tax Collector Erick Roeser.

The median annual tax revenue collected by the county in recent years from cannabis operators is $2.5 million, according to a staff report. That total does not include revenue brought in from code violation penalties.

The board has the option to extend the tax delay beyond April 30 and is due to discuss potential long-term relief options on March 15.

You can reach Staff Writer Emma Murphy at 707-521-5228 or On Twitter @MurphReports.

Meet Uncle Budd, the new NYC cannabis operation – FOX 5 NY

On 116th St. in Harlem, there’s no famous tree, like the one that grows in Brooklyn. But there is a budding business, Uncle Budd that is. A lime green hitched trailer that’s parked seemingly between Prohibition and Amsterdam.

FOX 5 News met with a man, Attaché, the ambassador of the Uncle Budd operation. Their product, is marijuana. And their community is Harlem.

The bold part of their existence is that while recreational marijuana for adults was decriminalized in New York State last year, the sale of weed is as illegal as it ever was. The process to establish state regulations for sales was interrupted when Governor Cuomo resigned amid scandal. Making this high visibility business, remarkable.

„We just wanted to bring good quality products to the community,” Attaché says.  „You have people of all walks. They come in business suits, elderly, younger, 21 years and older.”

The truck it’s off could not be easier to find, there is a neon sign on top. And the vehicle is in part surreptitiously on some side street, but right at the busy intersection of Frederick Douglass Boulevard.

Open from morning until night, for what we witnessed to be a diverse customer base. As visible as it is, it seems invisible to authorities as we watched police cars zip on by, some pulled up a few steps away to investigate an unrelated assault. Not so much as a glance was paid to the truck.

The operation let FOX 5 News in to see how it works. The products are catchy, resembling a lineup at your local bodega. Only these products contain medical-grade marijuana for recreational use.

There’s a QR code on the side of the truck that pulls up their entire stock on a phone. Listing the properties of each item in detail, what it contains, what kind of flower, how it affects a person and which ailments it’s designed to relieve. Products range from $10-$30, including edibles.

When Uncle Budd first opened up at the Harlem location in September, they had some problems with local law enforcement. It’s not illegal to be in possession of marijuana, to sell it is a different story. But they found an ingenious way to get around it, just like at some museums they work off of suggested donations. A civic compromise if you will.

The greatest challenge ahead for the team behind Uncle Budd comes as New York State develops the rules for who can sell marijuana. There are those who want to automatically bar anyone with a criminal record from being allowed to sell. But such a stipulation would disproportionately disqualify residents from neighborhoods like this one where many have been arrested for marijuana fences.

„There’s plenty of people locked up for smoke and joint walking down the street,” Attaché says.  „But these people are so smart, still going to school… so they should actually allow these people who have been locked up with these criminal records to give them a chance to on their own and actually do it in a professional way.”

Attaché says the money they earn stays in the neighborhood instead of going to a corporation outside of New York with stockholders, outside of New York. And he only hires locally because he says, those are the people who deserve a chance at a professional career.

A bit to cultivate the business side of a budding industry. 

Is too much THC bad for you? Animal study links THC to testicular failure – Deseret News

A new animal study reveals that heavy use of cannabis can contribute to lower semen volume, decreased hormone production and testicular atrophy.

Researchers tracked for seven months the effects of a cohort of male rhesus macaques eating a daily cookie before breakfast containing tetrahydrocannabinol, or THC, which is the chemical responsible for marijuana’s psychoactive effects. The macaque subjects had previously fathered offspring.

As the dose of THC was gradually increased over the study period, researchers tracked the effect of exposure on the subjects’ testes and reproductive health.

Researchers collected blood and semen samples from the research subjects and performed scrotal ultrasounds to measure testicular volume of the macaques at the Oregon National Primate Research Center.

According to the study, published in the journal Fertility and Sterility, the macaques’ testicular volume decreased by 58% by the end of the study period.

A change in hormone levels was also observed, including a decrease in testosterone. Semen volume was also reduced but no statistically significant drop in sperm count was observed.

The study concluded: “In rhesus macaques, chronic exposure to THC resulted in significant dose-response testicular atrophy, increased serum gonadotropin levels, and decreased serum sex steroids, suggestive of primary testicular failure. Further studies are needed to determine if reversal of these observed adverse effects would occur if THC was discontinued and for validation of the findings in a human cohort.”

Dr. Marcelle Cedars, president of the American Society for Reproductive Medicine, said in a statement as growing numbers of jurisdictions legalize cannabis for medical and recreational use, it is vital that medical science understand its impact on health, including reproduction.

“This study raises some important concerns, ones that need to be more fully explored,” Cedars said.

In approximately 40% of infertile of human couples, the male partner is either the sole cause or a contributing cause of infertility, according to the society’s website.

Thailand gives green light to growing cannabis at home amid push to promote it as a cash crop – ABC News

Thailand’s narcotics board is removing cannabis from its drugs list, paving the way for households to grow the plant. 

Under the new rule, people can grow marijuana plants at home after notifying their local government, but the cannabis cannot be used for commercial purposes without further licences, Health Minister Anutin Charnvirakul told reporters on Tuesday.

The rule must be published in the official Royal Gazette and 120 days must pass before home cannabis plants will become legal.

Police and lawyers contacted by The Associated Press said it was unclear if possession of marijuana would no longer be an offence subject to arrest.

A tangle of related laws means that production and possession of marijuana remains regulated for the time being, leaving the legal status of recreational marijuana use in a grey area. 

The government is expected to propose in Parliament a draft Cannabis Act on Wednesday to clarify the drug’s legal status.  

Food and drug regulator chief Paisal Dankhum has previously said homegrown cannabis should be used for medical purposes like traditional medicine, and there would be random inspections.

The draft bill punishes growth of cannabis without notifying the government with a fine of up to 20,000 baht ($850) and prescribes a fine of up to 300,000 baht ($12,700) or three years in jail, or both, for selling it without a license.

A new approach

The move is the latest step in Thailand’s plan to promote cannabis as a cash crop. About a third of its labour force works in agriculture, according to the World Bank.

First outlawed in 1935, marijuana has reportedly been a part of traditional Thai medicine and cooking for centuries, mainly used as a versatile form of pain relief.

Thailand legalised medical marijuana in December 2018, making it the first country in South-East Asia to do so.

The military-dominated parliament voted to amend the 1979 Narcotic Act to approve the use of marijuana for medical use and research, calling it a „New Year’s gift” to the Thai people.

Thai drinks and cosmetics companies last year rushed to launch products with hemp and CBD, a compound that does not give users a high, after their use was approved for consumer goods.